Söndag 22 December | 08:50:53 Europe / Stockholm

Kalender

Tid*
2025-08-28 08:00 Kvartalsrapport 2025-Q2
2025-04-04 N/A Årsstämma
2025-03-07 08:00 Bokslutskommuniké 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-04-05 - X-dag ordinarie utdelning AIFORIA 0.00 EUR
2024-04-04 - Årsstämma
2024-03-07 - Bokslutskommuniké 2023
2023-08-25 - Kvartalsrapport 2023-Q2
2023-03-31 - X-dag ordinarie utdelning AIFORIA 0.00 EUR
2023-03-30 - Årsstämma
2023-03-02 - Bokslutskommuniké 2022
2022-08-25 - Kvartalsrapport 2022-Q2
2022-04-06 - X-dag ordinarie utdelning AIFORIA 0.00 EUR
2022-04-05 - Årsstämma
2022-03-02 - Bokslutskommuniké 2021

Beskrivning

LandFinland
ListaFirst North Finland
SektorInformationsteknik
IndustriProgramvara
Aiforia Technologies utrustar patologer och forskare i prekliniska och kliniska laboratorier med programvara för att översätta bilder till upptäckter, beslut och diagnoser. Bolagets produkter och tjänster används för medicinsk bildanalys, över en mängd olika områden från onkologi till neurovetenskap. Aiforia Technologies har sitt huvudkontor i Finland.
2024-12-02 13:00:00

Aiforia Technologies Plc, Press Release, December 2, 2024 at 02:00 p.m. EET

Memorial Hospitals Group in Turkey selects Aiforia as the partner for AI-assisted clinical diagnostics in pathology

Memorial Hospitals Group in Turkey has selected Aiforia Technologies Plc as a partner for AI-assisted pathology image analysis in clinical diagnostics. The collaboration involves the use of Aiforia’s regulatory-approved clinical AI solutions for the analysis of tissue samples from breast, prostate, and lung cancer patients at the Memorial Pathology.

“We are proud to be the first pathology lab in Turkey with full digital workflow and fully digitized for biopsies. Next step was to include clinical AI use, and now we are happy to reach this level with Aiforia. We will use Aiforia’s AI models for prostate, breast and lung carcinoma patients and they will assist us in our diagnostic path. We are happy that we can offer the most innovative and comprehensive diagnostic tools to our patients. We will expand our scope and tools with further collaborations in other disease groups in future,” says Dr. İlknur Turkmen, Director of Pathology at Memorial Hospital Group 

“We are excited to support Memorial Pathology on their journey towards bringing the benefits of AI-powered diagnostics to their pathology practice. We are confident that our clinical solutions will meet the needs of pathologists, improving diagnostic confidence and workflow efficiency, enabling them to deliver even better care to their patients,” says Jukka Tapaninen, CEO of Aiforia. 

Memorial Hospital Group is the largest private hospital group in Turkey, serving 75 thousand patients from more than 167 countries annually with 11 hospitals, two medical centers, and one wellness center in five Turkish cities.

Further inquiries

Jukka Tapaninen, CEO, Aiforia Technologies Plc

tel. +33 61 041 6686

https://investors.aiforia.com/

 

Certified Adviser

UB Corporate Finance Ltd

ubcf@unitedbankers.fi

 

About Aiforia

Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.

Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.

Find out more at www.aiforia.com